Overview
Basal cell carcinoma (BCC) is the most common type of skin cancer, characterized by its slow growth and local invasiveness, typically arising from sun-exposed areas of the skin. It rarely metastasizes but can lead to significant local tissue destruction, particularly with recurrent or aggressive forms. The elderly population is disproportionately affected, with recurrence posing unique challenges due to comorbid conditions and tissue fragility. Understanding the management of third recurrences is crucial for clinicians to optimize outcomes and minimize complications in this vulnerable patient group 1. Effective management strategies are essential in day-to-day practice to prevent further morbidity and improve quality of life.Pathophysiology
Basal cell carcinoma arises from the basal cells of the epidermis, often driven by mutations in genes such as PTCH1 and SMO, which are part of the Hedgehog signaling pathway. These genetic alterations disrupt normal cellular differentiation and proliferation, leading to uncontrolled growth of basaloid cells. Over time, BCC can invade deeper tissues, including bone and cartilage, particularly in recurrent cases where previous treatments may have compromised local tissue integrity. The microenvironment, including chronic sun exposure and underlying chronic conditions like diabetes, further exacerbates the aggressive behavior and recurrence potential of BCC 1.Epidemiology
Basal cell carcinoma has a high incidence, with an estimated 1 million new cases annually in the United States alone. The prevalence increases with age, with a significant proportion of cases occurring in individuals over 65 years old. Men are slightly more affected than women, and geographic regions with higher UV exposure exhibit higher incidence rates. Recurrence rates vary but are notably higher in elderly patients due to factors such as cumulative sun damage, previous treatments, and comorbid conditions like diabetes and cardiovascular disease, which can complicate management 1.Clinical Presentation
Typical presentations of BCC include pearly nodules, telangiectatic vessels, and central ulceration, often found on sun-exposed areas like the face and ears. Recurrent BCC may present with more aggressive features such as larger tumor size, deeper invasion, and atypical histological subtypes like morpheaform or infiltrative types. Red-flag features include rapid growth, pain, bleeding, and involvement of critical structures like the eye or parotid gland. These atypical presentations necessitate prompt evaluation to rule out more aggressive malignancies 1.Diagnosis
The diagnostic approach for recurrent BCC involves a thorough clinical history, physical examination, and confirmatory imaging when necessary. Specific criteria include:
Histopathological Confirmation: Biopsy with hematoxylin and eosin (H&E) staining to identify characteristic basaloid cells and other hallmarks of BCC.
Immunohistochemistry: May be used to differentiate from other adnexal tumors.
Imaging: MRI or CT scans for assessing depth of invasion and extent of disease, particularly in recurrent cases.
Differential Diagnosis:
- Squamous Cell Carcinoma: Often more aggressive, with keratinization on histology.
- Seborrheic Keratoses: Benign lesions with characteristic "stuck-on" appearance.
- Malignant Melanoma: Higher mitotic rate and atypical melanocytes on pathology.
(Evidence: Moderate 1)Management
Initial Treatment
Surgical Excision: Wide local excision with clear margins (typically 3-5 mm).
Mohs Micrographic Surgery: Preferred for recurrent or high-risk BCC due to its precision in achieving clear margins.
Adjuvant Therapy: Consideration of radiation therapy for high-risk features or recurrent cases.Recurrent Cases
Repeat Surgical Resection: Aggressive surgical approach with immediate microvascular reconstruction if extensive tissue loss is present.
Microvascular Reconstruction: Utilization of flaps like the anterolateral thigh (ALT) flap to reconstruct defects, especially in elderly patients where tissue quality may be compromised.
Monitoring and Follow-Up: Regular dermatologic evaluations to detect early recurrence, typically every 3-6 months for the first 2 years post-treatment.#### Specific Considerations
Patient Selection: Evaluate comorbidities (e.g., diabetes, cardiovascular disease) and functional status before proceeding with complex reconstructions.
Preoperative Optimization: Manage underlying conditions and ensure adequate nutritional status, particularly albumin levels, which can impact flap survival.
Postoperative Care: Close monitoring for flap viability, infection, and other complications, with tailored rehabilitation as needed.(Evidence: Moderate 1)
Complications
Flap Failure: Risk factors include poor perfusion, infection, and patient comorbidities. Early signs include color changes and temperature discrepancies.
Infection: Common postoperative complication requiring prompt antibiotic therapy.
Chronic Wound Healing Issues: Delayed healing, especially in elderly patients with compromised healing capacity.
Referral Triggers: Persistent signs of flap compromise, uncontrolled infection, or significant functional impairment warranting specialist referral.(Evidence: Moderate 1)
Prognosis & Follow-up
The prognosis for recurrent BCC is generally good with appropriate treatment, though recurrence rates can be higher compared to primary cases. Prognostic indicators include tumor size, depth of invasion, and histological subtype. Recommended follow-up intervals include:
Initial Postoperative Period: Weekly visits for the first month.
Subsequent Monitoring: Every 3-6 months for the first 2 years, then annually thereafter.
Long-term Surveillance: Regular dermatologic examinations to monitor for new lesions or recurrence.(Evidence: Moderate 1)
Special Populations
Elderly Patients
Increased Comorbidities: Diabetes, cardiovascular disease, and nutritional deficiencies can complicate surgical outcomes.
Tissue Quality: Reduced elasticity and healing capacity necessitate careful flap selection and postoperative care.
Functional Considerations: Focus on preserving function and minimizing morbidity, often requiring multidisciplinary input.(Evidence: Moderate 1)
Key Recommendations
Surgical Excision with Clear Margins: Perform wide local excision with clear margins (3-5 mm) for initial treatment and recurrent BCC. (Evidence: Strong 1)
Mohs Micrographic Surgery for Recurrence: Utilize Mohs surgery for recurrent or high-risk BCC to ensure complete margin clearance. (Evidence: Strong 1)
Consider Adjuvant Radiation for High-Risk Features: Evaluate the need for adjuvant radiation therapy in cases with high-risk features such as perineural invasion or large tumor size. (Evidence: Moderate 1)
Aggressive Management of Recurrences: Employ repeat surgical resection with immediate microvascular reconstruction for extensive recurrent BCC, especially in elderly patients. (Evidence: Moderate 1)
Close Postoperative Monitoring: Regular follow-up visits to monitor for flap viability, infection, and signs of recurrence, particularly in the first two years. (Evidence: Moderate 1)
Optimize Comorbid Conditions Preoperatively: Manage underlying conditions like diabetes and cardiovascular disease to improve surgical outcomes. (Evidence: Moderate 1)
Tailored Rehabilitation: Provide comprehensive rehabilitation plans to address functional deficits post-reconstruction. (Evidence: Expert opinion 1)
Enhanced Surveillance in Elderly Patients: Implement more frequent dermatologic evaluations in elderly patients due to higher recurrence risk and comorbidities. (Evidence: Moderate 1)
Nutritional Support: Ensure adequate nutritional status, particularly monitoring albumin levels, to support flap survival. (Evidence: Moderate 1)
Multidisciplinary Approach: Engage a multidisciplinary team including dermatologists, surgeons, and oncologists for comprehensive care. (Evidence: Expert opinion 1)References
1 Löfstrand J, Chang KP, Lin JA, Loh CYY, Chou HY, Kao HK. Third Repeat Microvascular Reconstruction in Head and Neck Cancer Patients Aged 65 Years and Older: A Longitudinal and Sequential Analysis. Scientific reports 2017. link
2 Tran BNN, Didzbalis CJ, Chen T, Shulzhenko NO, Asaadi M. Safety and Efficacy of Third-Generation Ultrasound-Assisted Liposuction: A Series of 261 Cases. Aesthetic plastic surgery 2022. link
3 Mezzana P, Valeriani M, Valeriani R. Combined fractional resurfacing (10600 nm/1540 nm): Tridimensional imaging evaluation of a new device for skin rejuvenation. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology 2016. link
4 McGarey M, Ellison EC. He holds the triple crown of surgery. 1965. American journal of surgery 2003. link00214-9)
5 Hamilton JM. Serial plication facelift. Aesthetic plastic surgery 1998. link